Search results

Etanercept (Enbrel®)

Psoriatic arthritis

etanercept (Enbrel)

for the treatment of severe active ankylosing spondylitis.

etanercept (Enbrel)

for the treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.

etanercept (Enbrel)

For the treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents

etanercept (Enbrel)

for the treatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.

etanercept (Enbrel)

Chronic severe plaque psoriasis in children and adolescents

etanercept 50mg subcutaneous injection (Enbrel)

Psoriatic arthritis

etanercept 50mg subcutaneous injection (Enbrel)

Rheumatoid Arthritis

etanercept 50mg subcutaneous injection (Enbrel)

for the treatment of ankylosing spondylitis.

NICE Multiple Technology Appraisal (MTA)

Healthcare Improvement Scotland advises on adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed.